That's a great question about combining Namenda (memantine) with Qulipta (atogepant) for migraine prevention. Unfortunately, this specific combination isn't covered in the available information here, so it's really important to speak directly with a doctor or pharmacist about it.
What is known about Qulipta (atogepant) on Show Full Answer
That's a great question about combining Namenda (memantine) with Qulipta (atogepant) for migraine prevention. Unfortunately, this specific combination isn't covered in the available information here, so it's really important to speak directly with a doctor or pharmacist about it.
What is known about Qulipta (atogepant) on its own is worth sharing though! Atogepant (Qulipta) is an oral medication taken once daily to help prevent both episodic and chronic migraine. It works by blocking CGRP receptors, which stops a protein called CGRP from triggering the migraine process.
In clinical trials, atogepant reduced migraine days by about 4 per month compared to roughly 3 days for those on a placebo — a meaningful difference for many people.
Common side effects to be aware of include:
- Nausea
- Constipation
- Fatigue
- Possible allergic reactions (rash or shortness of breath)
Because memantine works on a completely different brain pathway (NMDA receptors), a prescribing doctor or pharmacist would be the safest resource to assess whether combining it with atogepant is appropriate and safe for a specific situation. Drug interactions are always worth double-checking before starting any new combination.
July 28